Clinical Trial Update: T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a Phase 1/Phase 2 clinical trial evaluating T cell immunotherapy for patients with multiple myeloma undergoing bone marrow t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• T cell immunotherapy

Snippet

Sponsor: Xcyte Therapies | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: UNKNOWN